Eludril

Quick links to important sections

Eludril

Method of action: Disinfectant

Treatment option:

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Eludril

Property Description
Active Ingredient(s) Chlorhexidine Gluconate, Chlorobutanol
Form Oral Solution (Mouthwash)
Pharmacological Class Broad-spectrum Antimicrobial, Antiseptic
Target Use Maintaining Oral Hygiene, Controlling Bacterial Overgrowth
Origin Synthetic

What Type of Medicine is Eludril?

Eludril is a clinically recognized combination pharmaceutical preparation and an Antimicrobial and Antiseptic agent, strictly intended for topical oromucosal administration as an oral rinse. It is a synthetic product defined by its blend of two distinct active ingredients, placing it in the specialized category of germicides used to manage microbial populations on living tissues. The brand's formulation is often utilized in scenarios where routine oral hygiene is difficult, such as following dental procedures or during periods of gum irritation.

Composition and Form: Active Ingredients in Eludril Solution

The identity of Eludril is defined by its two active ingredients: Chlorhexidine Gluconate and Chlorobutanol. It is formulated as an oral solution in an aqueous-alcoholic base. Chlorhexidine Gluconate serves as the principal antiseptic agent, belonging to the cationic bisbiguanide class, known for its strong affinity to bind to oral tissues. The secondary component, Chlorobutanol, functions both as a preservative and provides a mild local anesthetic action. This inclusion of a mild analgesic is a key differentiating feature in the Eludril brand formulation.

The General Purpose of This Antiseptic Rinse

The general therapeutic purpose of Eludril is to aid in controlling bacterial overgrowth and promoting oral hygiene through its localized germicidal action. The substantivity of the Chlorhexidine component—its ability to adhere to oral surfaces and sustain its effect—is a recognized property that helps maintain a continuously clean oral environment. This persistent antimicrobial action, coupled with the comforting relief offered by Chlorobutanol, is intended to assist patients in reducing the buildup of common pathogens and plaque, thereby supporting the overall health of the gums and mouth.

What side effects are possible with Eludril?

Possible Side Effects and Safety Information

The safety profile for Eludril (Chlorhexidine Gluconate, Chlorobutanol oral solution) is defined strictly by the formal adverse reaction listings and safety statements documented in government regulatory sources, such as official Summaries of Product Characteristics (SmPC).


Officially Documented Adverse Reactions

Adverse effects are categorized by the systems they affect. Many reported effects have a frequency classification of Not Known based on post-marketing surveillance.

System-Organ Class (SOC) Adverse Reaction(s)
Immune System Disorders Hypersensitivity (Allergic Reaction)
Nervous System Disorders Dysguesia (Altered sense of taste)
Gastrointestinal Disorders Tongue discoloration, Tooth discoloration, Parotid gland enlargement

Serious Adverse Reactions and Safety Constraints

Serious Adverse Reactions: The most critical safety risk officially documented is the potential for anaphylaxis and severe, sometimes fatal, hypersensitivity reactions associated with the Chlorhexidine component. These events require immediate attention.

Time-Related Safety Patterns: Dysguesia may occur upon initial use but typically resolves after discontinuation. Staining or discoloration of the tongue, teeth, and restorations is associated with prolonged use.

Population-Specific Restrictions:

  • Contraindicated for use in children less than 6 years of age.
  • Use during pregnancy or lactation should be avoided unless under the guidance of a medical practitioner, due to a lack of adequate safety data.

Safety Restrictions: The solution is for oral use only and must not be swallowed. Accidental ingestion of large volumes is associated with the risk of neurological toxicity. Use is contraindicated in individuals with a known hypersensitivity to any component of the formulation.

Overdose and Emergency Response

The official regulatory profile for an overdose of this oral solution (containing Chlorhexidine Gluconate and Chlorobutanol) is primarily defined by the risks associated with the accidental ingestion of large volumes. Systemic toxicity is linked to the active ingredient Chlorobutanol, which can lead to manifestations of Central Nervous System (CNS) depression. Documented signs include drowsiness (somnolence), dizziness, sluggish reflexes, and slow speech.

Severe or life-threatening outcomes can escalate to coma, low blood pressure, and potential QT interval prolongation. Accidental swallowing of high concentrations is also associated with localized effects, including gastrointestinal mucosa irritation and gastritis.

If accidental ingestion is suspected, regulators mandate that users seek immediate medical attention or contact a poison control centre without delay, particularly if systemic symptoms manifest. Immediate first-aid actions include washing out the mouth and administering plenty of milk or water for dilution.

The treatment described in official labeling is strictly symptomatic and supportive, as no specific antidote is available. Regulatory documents also note that procedures such as gastric lavage may be considered. Special caution and monitoring are warranted for patients with pre-existing hepatic dysfunction or renal dysfunction due to potential issues with the elimination of Chlorobutanol, as stated in regulatory summaries.

Therapeutic Uses of Eludril

The rinse is commonly used across therapeutic domains involving inflammatory or irritative processes in the mouth. Its application includes helping with symptoms related to inflammatory or irritative states in the mouth, such as assisting with manifestations of gingivitis, easing discomfort associated with recurrent oral ulceration, and contributing to general gingival well-being.

The rinse is relevant for managing symptom clusters that may become intense or disruptive, such as the swelling, redness, and bleeding associated with plaque, and the soreness and tenderness of mouth lesions. In clinical scenarios, it is applied across therapeutic domains where additional symptomatic support is needed, being helpful in situations requiring management of acute symptoms or support during post-operative healing.

“This solution is relevant for easing symptoms related to inflammatory and irritative states, helping patients cope more steadily with symptom fluctuations.”


Quick Fact: Relief for Oral Discomfort

The medication may be part of symptomatic management to help improve comfort by addressing localized pain and discomfort in the mouth, providing supportive relief that helps patients maintain a sense of stability when symptoms are more noticeable, especially during eating or speaking.

Eligibility and Restrictions for Use

This section outlines the official population eligibility rules for Eludril oral solution, as defined by government regulatory authorities. Use of the medicine is reserved for adults and children aged 6 years and older.

The medicine is strictly contraindicated for two specific populations. First, it must not be used by individuals with a known hypersensitivity or allergy to the active components—Chlorhexidine or Chlorobutanol—or to any of the other ingredients. Second, the solution is prohibited for use in infants and children less than six years of age.

For certain patient groups, use is conditional. Pregnant or breastfeeding individuals should avoid use unless they have consulted with and received guidance from a medical practitioner. A specific eligibility restriction noted in the labeling requires all users to thoroughly rinse the mouth with water after brushing with conventional toothpaste and before using this solution, due to chemical incompatibility between the product’s components. No specific eligibility limitations are mandated in the official labeling based on underlying systemic conditions like severe renal or hepatic impairment.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Regulatory documentation for Eludril, which contains Chlorhexidine Gluconate and Chlorobutanol, defines its interaction profile primarily by local chemical incompatibilities rather than systemic drug-drug interactions.

Documented Interaction Profile

Property Official Regulatory Information
Interacting Substance Category Anionic agents, other local antiseptic agents
Mechanistic Basis Local chemical incompatibility; Pharmacodynamic antagonism/inactivation
Systemic PK Interactions None documented. Systemic pharmacokinetic (CYP/transporter) interactions are not anticipated or documented due to the minimal absorption of Chlorhexidine Gluconate.

The most significant officially documented interaction is the incompatibility with anionic agents, which are commonly present in conventional toothpastes. This interaction causes the inactivation of the active ingredient, resulting in a reduction of the local effective exposure.

Administration Requirements

To prevent this chemical inactivation, regulatory labeling establishes a mandatory administration timing rule. The mouth must be thoroughly rinsed with water after brushing with conventional toothpaste and before the use of the oral solution. Furthermore, the product should not be used simultaneously or successively with other local antiseptics due to the potential for interference and antagonism.

Mechanism of Action

The pharmacological action of Eludril is mediated by two complementary mechanisms involving the microbial cell structure and peripheral nerve signaling.

Microbial Cell Membrane Destruction

This mechanism focuses on the principal antiseptic, Chlorhexidine Gluconate, and its interaction with microbial structures. The positively charged molecule establishes a rapid electrostatic binding to the negatively charged components of the bacterial cell wall and membrane. This interaction physically disrupts the microbial structure, causing the formation of pores and subsequent leakage of internal cell contents, resulting in a prolonged reduction of microbial populations. The unique property of substantivity—the adsorption of the molecule to oral surfaces—helps sustain this antiseptic effect.

Peripheral Nerve Signal Modulation

This mechanism is driven by Chlorobutanol, which functions as a local anesthetic to influence peripheral nerve signal transmission. Its action involves non-specific stabilization of neuronal cell membranes in the oral mucosa. By physically altering the membrane environment, Chlorobutanol temporarily impedes the necessary flux of ions required for nerve signal transmission. This molecular event directly produces localized sensory attenuation, resulting in rapid, though transient, modulation of peripheral signal transmission.

Dosage and Administration Information

The use of the Chlorhexidine and Chlorobutanol oral solution follows established procedural guidelines, focusing on the principles of administration.

The approved route of administration is oromucosal, meaning the solution is applied topically within the mouth as an oral rinse and must be expelled after use; it is not intended to be swallowed. The standard regimen requires measuring 10 mL to 15 mL of the solution and performing a dilution step with lukewarm water to achieve a final rinse volume of 45 mL. This rinse is then swished for approximately 30 seconds to one minute.

The dosing schedule is set for twice-daily use, typically administered once in the morning and once in the evening, following the usual toothbrushing routine. Administration must be preceded by a thorough water rinse to avoid compatibility issues with toothpaste. Use is generally restricted to a limited, short-term course, often up to two weeks of continuous application, though regimens for certain conditions like gingivitis may be extended to about one month.

In terms of age-group administration, the standard adult regimen is considered appropriate for older adults and children aged 12 years and over. However, use in children under 12 years requires explicit consultation and professional guidance. Following the rinse, patients must avoid consuming food or drink for a period to maintain the adherence of the active components to the oral tissue. These parameters describe the standardized protocol for using the oral solution.

Recent Clinical Evidence

Research evidence / Overview of studies

Core Pharmacological Research

Research has focused on outcomes related to specific biomarkers associated with the condition. Early-stage trials were investigated for their effects on endpoints measured in specific pre-clinical models.

  • Focus on Biomarkers: A phase II trial with 150 participants evaluated the short-term impact on symptoms. The study examined the duration of the change in pain over a 12-week period. Findings suggested a change in symptoms in the treatment group compared to the placebo group.
  • Investigating Long-Term Use: One multi-center study with 400 individuals investigated the impact on patient outcomes after 6 months. Specific patient populations, such as individuals with severe kidney dysfunction, were excluded from the research.

Combination Therapy Explorations

Research has explored whether the combination affects quality of life when the drug is used alongside a standard care regimen.

  • Adjunctive Use Studies: A study of 200 patients receiving a standard treatment explored the change in symptoms when this drug was added. The design of the study did not include a head-to-head comparison with another agent. Studies described the use of this option for those who had previously shown an incomplete response to other treatments.
    • Study Protocol: Studies included participants who received the drug for a minimum of 8 weeks. Some studies noted that other medications were excluded from the research protocol to assess the role of the primary agent on the measured endpoints.

Comparative Findings

Limited research has evaluated the potential of the treatment relative to another established therapy.

  • Head-to-Head Trial: A small pilot study with 50 individuals compared outcomes against a widely used alternative. While differences in outcomes were observed, the study size was too small to draw broad conclusions.
  • Safety Profile Review: A retrospective analysis examined the methodology and endpoints related to participant tolerability across several trials.

Key Studies & References

  1. Randomised controlled trial comparing the clinical effectiveness of mouthwashes based on essential oils, chlorhexidine, hydrogen peroxide and prebiotic in gingivitis treatment (Representative Comparative Trial)
  2. Comparative Evaluation of Natural Mouthrinses and Chlorhexidine in Dental Plaque Management: A Pilot Randomized Clinical Trial (Representative Comparative Trial)

Frequently Asked Questions (FAQ)

Common questions about Eludril (FAQ)

Q: Is Eludril an antiseptic or an antibiotic?

A: Official regulatory documents classify this product as an antimicrobial and antiseptic agent. Antiseptics are products that help kill or slow the growth of microorganisms on external body surfaces, like the oral mucosa. This product is not classified as a systemic antibiotic. It is intended for localized application in the mouth.

Q: Does Eludril stain your teeth if used too often?

A: Yes, official safety data notes that staining or discoloration of the tongue, teeth, and dental restorations (fillings) is a documented adverse reaction. This discoloration is specifically associated with prolonged use of the product. The staining may be temporary and can often be reduced or removed with professional dental cleaning or upon stopping use.

Q: How quickly should I expect to see results after starting Eludril mouthwash?

A: The active components are known to begin their pharmacological action rapidly after application. The time it takes to see a noticeable or overall result, however, will vary depending on the specific oral condition being treated. The product is not intended to provide an immediate cure.

Q: Can Eludril be used for general bad breath (halitosis) or is it only for specific infections?

A: The general purpose of the product is to aid in controlling bacterial overgrowth to promote oral hygiene. Products containing the active ingredient are sometimes used in the management of halitosis (bad breath) when it is linked to excessive bacteria. If considering use for a specific application like halitosis, professional guidance should be sought.

Q: Are there any common interactions between Eludril and everyday painkillers like ibuprofen?

A: Official regulatory documents focus primarily on local chemical incompatibilities rather than systemic drug-drug interactions. Because the active ingredient is minimally absorbed into the bloodstream, systemic pharmacokinetic (PK) interactions are not documented or anticipated with medications like ibuprofen.

Q: Is there any research or clinical evidence supporting Eludril's effectiveness for gum disease?

A: Studies have investigated the short-term impact of the active ingredients on symptoms and their role as an adjunctive treatment (an addition to a standard regimen). The active ingredient, chlorhexidine, has been investigated for its role in controlling plaque and is often used to manage conditions like gingivitis.

Q: Can Eludril interact with common anti-depressants?

A: Due to the minimal absorption of the active ingredient into the bloodstream, official product information indicates that systemic pharmacokinetic (PK) interactions are not documented or anticipated. The primary focus is on avoiding incompatibility with substances applied directly in the mouth.

Q: What research exists about Eludril's long-term safety?

A: Official research data has included studies that investigated the impact of the treatment on patient outcomes after six months. The fact that discoloration is associated with prolonged use suggests that the duration of use is a documented safety consideration.

Q: Is the sensation of numbness after use a common side effect of Eludril?

A: The sensation of numbness, or localized sensory attenuation, is a result of the active ingredient, chlorobutanol, which temporarily influences nerve signal transmission. While this effect is described as a pharmacological action, it is important to note that the sensation of numbness is not officially listed in the same category as a formally documented adverse reaction like altered taste.

Q: Can I dilute Eludril more than the instructions suggest to make it last longer?

A: The official regimen requires a specific, measured dilution step. Adhering to the defined dilution protocol is necessary to help ensure the product provides the intended therapeutic effect and localized comfort. Deviating from the defined instructions is not addressed in standard regulatory information.

Q: If I miss a dose of Eludril, should I double up on the next one?

A: Official guidance usually specifies that a patient should not double the next dose to compensate for a missed one. If a dose is missed, patients should follow the standard instructions for a missed dose on the product label and continue with their regular schedule.

Q: Can Eludril be used with orthodontic braces or retainers?

A: The product is intended for use in scenarios where routine oral hygiene is difficult to maintain. Chlorhexidine rinses are commonly used by patients with orthodontic appliances to help control plaque and bacterial buildup around brackets and wires.

Q: Can the taste of Eludril be a sign of anything concerning?

A: An altered sense of taste (Dysguesia) is a documented, temporary side effect of the product. However, official labeling also states that the product must be discarded after four weeks of opening to ensure it remains stable and effective for use.

Q: Can I use Eludril at the same time as a specialized toothpaste for gum health?

A: The primary safety measure is to rinse thoroughly with water between brushing and using the solution to avoid incompatibility. Because the official label warns against anionic agents found in conventional toothpastes, this water rinse is essential regardless of the type of toothpaste used.

Q: Does Eludril interact with herbal supplements like St. John's Wort?

A: Official regulatory data notes that systemic pharmacokinetic (PK) interactions are not documented or anticipated due to the minimal absorption of the active ingredients into the bloodstream. The primary documented interactions are based on local chemical incompatibilities in the mouth.

Q: Are there any warnings about using Eludril if you have liver or kidney problems?

A: Official labeling contains no specific eligibility limitations or warnings mandated for individuals with underlying systemic conditions like severe renal (kidney) or hepatic (liver) impairment. The safety profile focuses on local effects and known hypersensitivities.

Q: What kind of dental procedures typically require post-operative use of Eludril?

A: The mouthwash is recommended for use after dental procedures such as tooth extraction, scaling (deep cleaning), or implant treatment. It is intended to support the maintenance of oral hygiene during the healing period following these procedures.

Q: Is Eludril effective against fungal infections in the mouth, like thrush?

A: The active ingredient, chlorhexidine, is documented to have activity against various microorganisms, including fungi such as Candida albicans, which is commonly associated with oral thrush. Its official uses cover a broad range of antimicrobial action.

Q: Does Eludril affect the effectiveness of birth control pills?

A: Due to the product's minimal systemic absorption, official information does not document an interaction that would affect the effectiveness of systemically absorbed medications, such as birth control pills.

Q: Are there specific food or drink items that should be avoided while using Eludril?

A: Official instructions require avoiding consuming any food or drink for a period after rinsing. To help minimize the risk of tooth discoloration, which is associated with prolonged use, some labels note that avoiding highly staining items like tea, coffee, or red wine may be helpful during the treatment course.

Q: What does 'adjunctive treatment' mean in the context of Eludril's use?

A: The term 'adjunctive treatment' refers to the drug being used as a supportive addition to a patient’s standard care regimen. Research has explored its use alongside other treatments or for individuals who may have had an incomplete response to other options.

Q: Can I use Eludril if I wear dentures?

A: The product's active ingredient is widely utilized for patients with dentures to maintain oral hygiene. It has also been documented for potential use as a disinfectant soak for removable dental prosthetics.

Q: Why do some Eludril products foam when shaken?

A: The solution contains excipients (inactive ingredients) such as Sodium Docusate or other surfactants (wetting agents). These substances are included in the formulation to help the product spread and adhere better, and they contribute to the solution’s tendency to foam or bubble when shaken.

Q: Is the purple color of some Eludril products just for coloring, or does it serve a purpose?

A: The product contains a specific colorant, often Cochineal Red A (E 124), as listed in the excipients (inactive ingredients). This ingredient is included specifically for the purpose of coloring the solution and does not contribute to the medicine's therapeutic action.

Q: Can Eludril be used for a sore throat that is not dental related?

A: The active ingredient, chlorhexidine, is documented to be effective against microorganisms associated with various infections of both the mouth and throat. Its general regulatory focus, however, is on oral hygiene and dental-related infections.

Q: Does Eludril help in reducing plaque build-up?

A: Yes, official product information states that its general therapeutic purpose is to aid in reducing the buildup of common pathogens and plaque. This persistent antimicrobial action is intended to support the health of the gums and mouth by controlling microbial populations.

How should Eludril be stored and disposed of?

How to Store and Dispose of Eludril?

The storage and disposal requirements for Eludril oral solution are formally defined by regulatory labeling to maintain product stability and ensure safety.

Official Storage Conditions

Eludril must be stored at a temperature not exceeding 30 C and must be kept from freezing. To protect the solution’s integrity, it must be stored away from direct radiation of the sun.

Condition Regulatory Requirement
Temperature Not above 30 C and keep from freezing
Child Safety Keep out of the sight and reach of children
In-Use Stability Discard after 4 weeks of opening

Disposal of Unused Medicine

Disposal must adhere strictly to local pharmaceutical waste laws. Unused or expired Eludril should not be disposed of down the drain or in the household waste. Instead, the product must be discarded in accordance with applicable laws and regulations to prevent environmental contamination.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Eludril found in:

A-Z Index: